Abstract: 2 ,3 -iso-Benzoabscisic acid (iso-PhABA), an excellent selective abscisic acid (ABA) analog, was developed in our previous work. In order to find its more structure-activity information, some structural modifications were completed in this paper, including the substitution of phenyl ring and replacing the ring with heterocycles. Thus, 16 novel analogs of iso-PhABA were synthesized and screened with three bioassays, Arabidopsis and lettuce seed germination and rice seedling elongation. Some of them, i.e., 2 ,3 -iso-pyridoabscisic acid (iso-PyABA) and 2 ,3 -iso-franoabscisic acid (iso-FrABA), displayed good bioactivities that closed to iso-PhABA and natural (+)-ABA. Some others, for instance, substituted-iso-PhABA, exhibited certain selectivity to different physiological process when compared to iso-PhABA or (+)-ABA. These analogs not only provided new candidates of ABA-like synthetic plant growth regulators (PGRs) for practical application, but also new potential selective agonist/antagonist for probing the specific function of ABA receptors.
Introduction
The crucial role of abscisic acid (S-(+)-ABA 1, Figure 1 ) as a phytohormone in a wide variety of physiological processes of plants, including inhibiting or promoting growth, maintaining bud and seed dormancy, affecting flowering and sex differentiation, as well as conducting environmental stresses response [1] [2] [3] [4] [5] [6] [7] [8] , motivates numerous scientific investigations into the agricultural application of ABA. However, the widely using of abscisic acid (ABA) has been hindered by its rapid metabolism in plants and light isomerization in vitro [9] [10] [11] [12] [13] [14] [15] [16] [17] . Focusing on the development of metabolism resistant analogs, significant efforts were devoted by different researchers. For example, methoxyl [18] , alkynyl [19] , or fluorine atoms [20, 21] at the 8 or 9 -positionm and halogen atoms [22, 23] at the 3 -position had been introduced to avoid 8 -hydroxylation and Michael addition, and the corresponding analogs displayed excellent ABA-like activities. Nonetheless, they are too expensive to practical use in field due to their complicated synthetic routes.
A successful case of 8 -hydroxylation resistant analog was 2 ,3 -benzoabscisic acid 2 [24, 25] (Figure 1 ), which had excellent bioactivity and relatively efficient synthetic route. Inspired by this compound and iso-ABA 3 [26] , in our previous works, we had developed 2 ,3 -iso-Benzoabscisic acid (iso-PhABA) 4a [27] , which is an excellent and easier preparation ABA analog. The deeply investigations of bioactivity and agonist-receptor interactions for 4a suggested that it is a state-of-art ABA-like regulator and a selective ABA agonist, i.e., PYL10 has the highest inhibitory effect on the phosphatase activity of HAB1 in the presence of (+)-iso-PhABA. Meanwhile, the analysis on 
Results and Discussion

Chemistry
As shown in Scheme 1, to obtain target compounds substituted-iso-PhABA (4b-4d) and heterocyclic analogs 2',3'-iso-heterocylicABA (iso-HetABA, 5a-5d, 6), four different pathways (a-d in Scheme 1) for the preparation of dicarbonyl intermediates 9b-9d, 13a-13d, and 17 were established, respectively. Firstly, the preparation of intermediates 9b-9d (Scheme 1a) were followed the similar pathway of the synthesis of 2′,3′-iso-PhABA 4 [25, 27] , comprising the vicinal methylation of the carbonyl of subtituted-1-tetralones (step i in Scheme 1a) to obtain 8b-8d and the oxidation of the benzyl carbon with Co(acac)2/t-BuOOH system [28] (step ii in Scheme 1a). Then, for the preparations of pyridine analogs 13a-13d, two different methods were applied for the intermediates 12a-12d. The reaction of multiple hydrophobic interactions. Thus, it provides a new and robust precursor for the design of ABA receptor agonists/antagonists. Consequently, in this work, we aimed at the further studies of the analogs of 2′,3′-iso-PhABA 4a to obtain more compounds with good ABA-like bioactivity and selective agonist/antagonists-receptor interactions. Here, we reported the synthesis and biological activity of substituted-iso-PhABA analogs 4b-4d and heterocyclic analogs 5 and 6 (see Figure 2 ). Their structure-activity relationship (SAR) was also discussed. 
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Scheme 1.
Synthesis of substitueted-iso-PhABA analogs 5 and heterocyclic analogs substituted-iso-HetABA 6. Reagents and conditions: (i) MeI, NaH, THF; (ii) Co(acac) 2 , t-BuOOH, acetone, r.t.; (iii) NH 4 OAc, toluene, reflux; (iv) 1,1,3,3-tetraethoxylpropane, p-toluenesulfonic acid, DMF, reflux; (v) With the diones in hands, the synthesis of the title compounds, i.e., substituted-iso-PhABA (4b-4d) and iso-HetABA analogs (5a-5d, 6), were performed following an efficient region-selective nucleophilic addition of alkynyl lithium, which was produced in situ by n-BuLi and (Z)-3-methylpent-2-en-4-yn-1-ol, to the less-steric 4-carbonyl of intermediates 18b-18d, 19a-19d, and 20 (step viii in Scheme 1) [34] . Then, the Red-Al was employed for the trans-selective reduction of alkynol to give enol 21b-21d, 22a-22d, and 23 (step ix in Scheme 1). The final products 4b-4d, 5a-5d, and 6 were yielded by a two steps oxidation (step x in Scheme 1), comprising Dess-Martin oxidation to form the aldehydes and then Lindgren oxidation to give the acids 5 and 6. Furthermore, the alkynol intermediates 18-20 were also followed the two steps oxidation to give the acetylenic acid analogs 24b-24d, 25a, 25b, 25d, and 26 (except 2 -n-Pr-iso-PyABA), since they are good materials for the screening of structural requirement of the trans-double bond of ABA analogs. Meanwhile, the acetylenic iso-PhABA 24a was synthesized following the similar pathway of 24b-24d, with the known intermediate (
Structure-Activity Relationship
The Arabidopsis, lettuce seed germination and the rice seedling elongation inhibiting tests in vivo were conducted to gain insights into the bioactivity of these iso-PhABA analogs. The (±)-iso-PhABA 4a and (+)-ABA 1 were used as the control agents. The corresponding data of bioactivities were summarized in Table 1 . For the comparison between the bioactivities of substituted-iso-PhABA analogs, the overall bioactivity of 4b-4d were very close to those of each other, indicating that the effects of electron-donating and withdrawing groups, as well as their substituted-positions (7 and 6 ) were not crucial for their bioactivity. However, the bioactivities of all the substituted-iso-PhABA 4b-4d were worse than those of the control agents 4a and 1, suggesting that a substituent in the benzene ring of iso-PhABA had a significant impact on the bioactivity. Furthermore, there were some preferences of substituted-iso-PhABA to different physiologic process. Compound 4b-4d observed the highest IC 50 values for the rice seedlings elongation, which was the lowest values for both the two control agents 4a and 1, indicating their different preferential nature of bioactivity compared to iso-PhABA. For the bioactivity of the heterocyclic analogs iso-HetABA, the compounds without substituent, i.e., 2 ,3 -iso-pyridoabscisic acid (iso-PyABA) 5a and 2 ,3 -iso-franoabscisic acid (iso-FrABA) 6, had good overall bioactivities, which were close to the control agents 4a and 1, suggesting the introducing of heteroatom (N for 5a and O for 6) in the aryl ring of iso-PhABA can mostly keep the bioactivity. To study the effect of the size of the substituted group on the bioactivity, compound 5b-5d were designed and synthesized for the bioassays, too. Obviously, the IC 50 values of these compounds are decreasing with the increasing size of the substituted, i.e., -Me 5b to -n-Pr 5c to -Ph 5d. Therefore, this evidence validated that a big group in the aryl ring is not preferential for the bioactivity.
In order to acquire more analogs for the discussion of structure-activity relationship, the acetylenic acids 24, 25, and 26 were also synthesized and tested with three bioassays. As shown in Table 1 , their bioactivities were significantly worse than those of their corresponding alkene acids 4, 5, and 6, suggesting the importance of the double-bond for the bioactivity. Besides, by the comparison between the acetylenic acids, acetylenic iso-PhABA 24a had the best activity for Arabidopsis seed germination (IC 50 = 1.38 µM), acetylenic 2 -Me-iso-PyABA 25b had the best activity for lettuce seed germination (IC 50 = 5.97 µM), and acetylenic iso-FrABA 26 had the lowest IC 50 value (4.32 µM) for rice seedlings elongation. Meanwhile, like the substituted-iso-PhABA analogs, there were obvious preferences of some acetylenic acids to different physiological process. For example, acetylenic 7 -OMe-iso-PhABA 24b showed a weakest inhibitor on Arabidopsis seed germination (IC 50 > 10 µM) in three bioassays; acetylenic 6 -Br-iso-PhABA 24d, on the other hand, had a lowest bioactivity on rice seedlings elongation (IC 50 > 10 µM). Hence, these results implied that there might be some difference in ABA signaling transduction between different acetylenic acids, as well as the acetylenic acids and alkene acids.
Materials and Methods
Materials and Instruments
Column chromatography was performed using silica gel (100-200 mesh) (Qindao Haiyang Co., Ltd., Qingdao, China). TLC was performed on GF254 silica gel plates (Qingdao Haiyang Co., Ltd., Qingdao, China). NMR spectra were recorded on a Bruker Avance DPX300 spectrometer (Bruker Corporation, Vienna, Austria) with TMS as the internal standard. HR-MS data were obtained on a Thermo FisherScientific LTQ Orbitrap (Thermo Fisher Scientific, Bremen, Germany) instrcument.
Synthesis
3.2.1. Synthesis of 9b-9d (Pathway a in Scheme 1, Use 9b as Example) 6-Methoxy-2,2-dimethyl-3,4-dihydronaphthalen-1(2H)-one (8b) [25, 27] : To a stirred solution of 6-methoxy-3,4-dihydronaphthalen-1(2H)-one 7b (10.0 g, 56.8 mmol) dissolved in dry tetrahydrofuran (THF, 150 mL) in a 500 mL round bottomed flask was added NaH (11.4 g, 284 mmol, 60% in oil). After stirring the mixture for 1 h under ice-water bath, methyl iodide (32.3 g, 227 mmol) in dry THF (50 mL) was added slowly. The mixture was allowed to stir at r.t. for 16 h. The reaction was quenched by addition of water (slowly and dropwise). The mixture was then extracted with ethyl acetate (3 × 100 mL), washed with water (2 × 100 mL), and dried over anhydrous Na 2 SO 4 . Evaporation of the solvent yielded a yellow oil. The residue was subjected to silica gel chromatography using petroleum ether (PE) and ethyl acetate (EtOAc) (10:1) as eluent to afford 6-methoxy-2,2-dimethyl-3,4-dihydronaphthalen-1(2H)-one 8b (10.4 g, yield 90%) as a yellow oil. 6-Methoxy-2,2-dimethyl-2,3-dihydronaphthalene-1,4-dione (9b) [27, 28] : To a stirred solution of 6-methoxy-2,2-dimethyl-3,4-dihydronaphthalen-1(2H)-one 8b (10.0 g, 49 mmol), peroxy-t-butanol (t-BuOOH, 62.8 g, 490 mmol, 70% aqueous) and Co(acac) 2 (1.26 g, 4.9 mmol) in 150 mL acetone at r.t. for 24 h. The mixture was then extracted with ethyl acetate (3 × 50 mL), washed with water (2 × 50 mL) and dried over anhydrous Na 2 SO 4 . Evaporation of the solvent yielded a brown oil. The residue was subjected to silica gel chromatography using PE and EtOAc (5:1) as eluent to afford 6-methoxy-2,2-dimethyl-2,3-dihydronaphthalene-1,4-dione 9b (7.7 3-Amino-5,5-dimethylcyclohex-2-enone (11) [29] : 5,5-dimethylcyclohexane-1,3-dione 10 (7.0 g, 50 mmol) was added to a mixture of ammonium acetate (3.85 g, 50 mmol) in dry toluene (100 mL). The mixture was heated for 5 h under reflux using a Dean-Stark water separator. The red oily layer formed was then separated and recrystallized with ethyl acetate to afford 3-amino-5,5-dimethylcyclohex-2-enone 11 (5.9 g, yield 85%) as a yellow solid. 1 H-NMR (300 MHz, DMSO-d 6 ) δ 6.67 (s, 2H), 4.90 (s, 1H), 2.11 (s, 2H), 1.90 (s, 2H), 0.96 (s, 6H). 7,7-Dimethyl-7,8-dihydroquinolin-5(6H)-one (12a) [29] : A solution of 1,1,3,3-tetraethoxylpropane (10 mL, 40 mmol), 3-amino-5,5-dimethylcyclohex-2-enone 11 (5.6 g, 40 mmol) and a catalytical amount of p-toluenesulfonic acid hydrate in DMF (50 mL) was heated under reflux for 18 h (monitored by TLC). The solvent was distilled in vacuo, the residue neutralized with NaHCO 3 , extracted with EtOAc (3 × 100 mL) and dried (anhydrous Na 2 SO 4 ). Column chromatography using PE and EtOAc (6:1) as eluent to afford 7,7-dimethyl-7,8-dihydroquinolin-5(6H)-one 12a ( 7,7-Dimethyl-6,7-dihydroquinoline-5,8-dione (13a): The synthesis of compound 13a was followed the same method as the synthesis of 9b using intermediate 12a as substrate.
7,7-Dimethyl-6,7-dihydroquinoline-5,8-dione 13a (yield 42%) as a yellow solid. 1 H-NMR (300 MHz, CDCl 3 ) δ 9.08 (dd, J = 4.6, 1.7 Hz, 1H), 8.37 (dd, J = 7.9, 1.8 Hz, 1H), 7.67 (dd, J = 7.9, 4.6 Hz, 1H), 3.02 (s, 2H), 1.37 (s, 6H). 13 4-(Dimethylamino)but-3-en-2-one (15b) [31] : To a mixture of acetone 14b (5.8 g, 100 mmol), in xylene (200 mL), was added dimethylformamide dimethylacetal (DMF-DMA, 11.9 g, 100 mmol) and the reaction refluxed for 15 h (monitored by TLC). The xylene was distilled off and the resulting solid residue was purified by column chromatography using PE and EtOAc (6:1) as eluent to afford 4-(dimethylamino)but-3-en-2-one 15b (4.3 g, 38%) as a yellow oil. 6,6-Dimethyl-6,7-dihydrobenzofuran-4(5H)-one (16) [32, 33] : To a stirred ice-cooled suspension of 5,5-dimethylcyclohexane-1,3-dione 10 (14 g, 100 mmol) in water (100 mL) was added dropwise a solution of KOH (7 g, 125 mmol) in water (100 mL). Then, KI (0.3 g, 20 mmol) was added to the resulting clear solution followed by the dropwise addition of 40% aqueous chloroacetaldehyde (ClCH 2 CHO, 20 mL) over 25 min. The reaction mixture was allowed to warm to reflux and stir overnight. The reaction was quenched by the dropwise addition of 2 M HCl until acid to pH paper. The solution was extracted by EtOAc (3 × 100 mL). The combined organic layers were dried (anhydrous Na 2 SO 4 ), concentrated, and vacuum distilled to afford 6,6-dimethyl-6,7-dihydrobenzofuran-4(5H)-one 16 (12.5 g, 76%) as a yellow oil. 18b-18d, 19a-19d and 20 (Use 18b as Example) [34] To a stirred solution of (Z)-3-methylpent-2-en-4-yn-1-ol (0.88 g, 9.2 mmol) in dry THF (20 mL) was cooled to −78 • C under an atmosphere of argon. n-Butyl lithium (7.7 mL, 18.4 mmol, 2.4 M in hexane) was then added slowly, via syringe. The mixture was allowed to stir at −78 • C for 1 h, after which, 6-methoxy-2,2-dimethyl-2,3-dihydronaphthalene-1,4-dione 9b (2 g, 9.2 mmol), dissolved in dry THF (10 mL) was added. The mixture was stirred for a further 1 h at −78 • C, and then the cold bath was removed. The reaction mixture was stirred at r.t. for a further 16 h. The reaction was quenched by addition of a saturated aqueous solution of NH 4 Cl. The mixture was stirred for 10 min and extracted with ethyl acetate (3 × 50 mL), washed with water (2 × 30 mL) and dried over anhydrous Na 2 SO 4 . Evaporation of the solvent yielded the desired alcohol as a yellowish oil. The residue was subjected to silica gel chromatography using PE and EtOAc (4:1) as eluent to afford (Z)-(1 -hydroxy-3 ,3 -dimethyl-4 -oxo-7 -methoxy-tetrahydronaphthalene-one-yl)-3-methylpentyl-2-em-4-yn-1-ol 18b (2.37 g, 82%) as a yellow oil. To a stirred solution of (Z)-(1 -hydroxy-3 ,3 -dimethyl-4 -oxo-7 -methoxy-tetrahydronaphthaleneone-yl)-3-methyl-pentyl-2-em-4-yn-1-ol 18b (1 g, 3.2 mmol) in dry THF (20 mL) was cooled to 0 • C and Red-Al reagent (2.9 mL, 9.6 mmol, 3.3 M in toluene) added dropwise via syringe. After 4 h stirring at r.t., the reaction was quenched by slow addition of saturate brine (10 mL) and extracted with diethyl ether (3 × 30 mL). The organic phase was washed with water (2 × 20 mL) and dried over anhydrous Na 2 SO 4 and filtered, filtrate concentrated under reduced pressure. The residue was subjected to silica gel chromatography using CH 2 Cl 2 and methanol (25:1) as eluent to afford (1E,3Z)-(1 ,4 -dihydroxy-3 ,3 -dimethyl-7 -methoxy-tetraloneyl)-3-methyl-pentyl-2-ene-4-yn-1-ol 21b (0.57 g, 56%) as a white solid. Title Compounds 4b-4d, 5a-5d, 6, 24a-24d, 25a, 25b , 25d and 26 (Use 4b as Example)
General Procedure for the Preparation of Intermediate
To a stirred solution of (1E,3Z)-(1 ,4 -dihydroxy-3 ,3 -dimethyl-7 -methoxy-tetraloneyl)-3-methylpentyl-2-ene-4-yn-1-ol 21b (0.5 g, 1.57 mmol), Dess-Martin periodinane (DMP, 1.32 g, 3.14 mmol) in 30 mL CH 2 Cl 2 at r.t. for 2 h. After added 5 mL aqueous Na 2 S 2 O 3 solution and 10 mL aqueous many important applications, including pointing out the direction for structural modification, practical application on the plant protection and probing the responding of different ABA receptors.
